"BPC" stands for "Body Protection Compound." In preclinical work it is proposed to act through several overlapping pathways, including promotion of new blood-vessel growth (angiogenesis), modulation of nitric-oxide signaling, and anti-inflammatory activity, rather than through one well-defined receptor mechanism the way a conventional small-molecule drug does

Evidence supporting a direct, weight-independent anti-inflammatory mechanism: CRP reductions in clinical trials appear only partly explained by weight loss (6) Anti-inflammatory effects are observed in cell culture and animal studies where weight loss is not a factor (8) Some patients show inflammatory marker improvement before significant weight loss occurs GLP-1 receptors on immune cells provide a clear mechanistic pathway independent of adipose tissue reduction The most likely reality is that semaglutide reduces inflammation through both pathways simultaneously direct immune modulation plus indirect effects from visceral fat reduction and metabolic improvement
Other formulations include: Byetta Victoza Trulicity Rybelsus Adlyxin Most either never gained the traction of the more modern formulations due to more intensive administration routines or less effective outcomes, however
Action produces results, results fuel motivation, and motivation transforms identity
Cheaper Tirzepatide Alternatives 2026 Tirzepatide is one of the most effective weight loss medicines available